Your email has been successfully added to our mailing list.

×
-0.00145812953358317 -0.00238099632699019 0.00223333764004508 0.0114620055741154 0.0206906735081858 0.0280736078554421 0.0225364070949998 0.0169992063345577
Stock impact report

CorMedix announces new commercial agreement [Seeking Alpha]

CorMedix Inc. (CRMD) 
NASDAQ:AMEX Investor Relations: cormedix.com
Company Research Source: Seeking Alpha
The company expects to initially target the utilization of DefenCath in up to 4,000 patients nationally, that would be prioritized based upon medical need. CorMedix received NDA approval of DefenCath under the Limited Population Pathway for Antibacterial and Antifungal Drugs on November 15, 2023, and began commercialization of the product in the inpatient setting on April 15, 2024. CorMedix anticipates shipments for DefenCath under this agreement to begin in the fourth quarter. CRMD is to $5.64. Recommended For You Recommended For You More Trending News About CRMD Stock Related Stocks Trending Analysis Trending News Show less Read more
Impact Snapshot
Event Time:
CRMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for CRMD alerts
Opt-in for
CRMD alerts

from News Quantified
Opt-in for
CRMD alerts

from News Quantified